181 related articles for article (PubMed ID: 35946973)
21. Alexithymia in different dermatologic patients.
Dehghani F; Dehghani F; Kafaie P; Taghizadeh MR
Asian J Psychiatr; 2017 Feb; 25():42-45. PubMed ID: 28262172
[TBL] [Abstract][Full Text] [Related]
22. Two paradoxical reactions in a patient with psoriasis and psoriatic arthritis: Adalimumab-induced hidradenitis suppurativa and secukinumab-induced alopecia areata.
Öğüt ND
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):e468-e469. PubMed ID: 36151938
[No Abstract] [Full Text] [Related]
23. A New Tool to Improve Communication Between Hidradenitis Suppurativa Patients and Health Care Providers.
Zundell MP; Merola JF; Gottlieb AB
J Drugs Dermatol; 2024 Feb; 23(2):105-109. PubMed ID: 38306140
[TBL] [Abstract][Full Text] [Related]
24. Off-Label Use of Baricitinib in Dermatology.
Shah A; Yumeen S; Qureshi A; Saliba E
J Drugs Dermatol; 2023 Aug; 22(8):795-801. PubMed ID: 37556530
[TBL] [Abstract][Full Text] [Related]
25. Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Helliwell PS; Gladman DD; Gottlieb AB
J Rheumatol Suppl; 2018 Jun; 94():1-3. PubMed ID: 29858345
[TBL] [Abstract][Full Text] [Related]
26. Prologue: 2019 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Callis Duffin K; Gladman DD; Goel N; Gottlieb AB
J Rheumatol Suppl; 2020 Jun; 96():1-3. PubMed ID: 32482760
[TBL] [Abstract][Full Text] [Related]
27. The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.
Leung YY; Orbai AM; Ogdie A; Coates LC; de Wit M; Callis Duffin K; Eder L; Gladman DD; Goel N; Mease PJ; Strand V; FitzGerald O; Tillett W
J Rheumatol Suppl; 2019 Jun; 95():33-37. PubMed ID: 31154402
[TBL] [Abstract][Full Text] [Related]
28. Prologue: 2020 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Duffin KC; Gottlieb AB; O'Sullivan D; Gladman DD; McFarland LV
J Rheumatol Suppl; 2021 Jun; 97():1-3. PubMed ID: 34074657
[TBL] [Abstract][Full Text] [Related]
29. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
[TBL] [Abstract][Full Text] [Related]
30. Racial and ethnic health disparities in dermatology in the United States. Part 2: Disease-specific epidemiology, characteristics, management, and outcomes.
Shao K; Hooper J; Feng H
J Am Acad Dermatol; 2022 Oct; 87(4):733-744. PubMed ID: 35143915
[TBL] [Abstract][Full Text] [Related]
31. Topical Janus kinase inhibitors: A review of applications in dermatology.
Hosking AM; Juhasz M; Mesinkovska NA
J Am Acad Dermatol; 2018 Sep; 79(3):535-544. PubMed ID: 29673776
[TBL] [Abstract][Full Text] [Related]
32. Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Baldness, and Hirsutism.
Vargas-Mora P; Morgado-Carrasco D
Actas Dermosifiliogr (Engl Ed); 2020 Oct; 111(8):639-649. PubMed ID: 32571540
[TBL] [Abstract][Full Text] [Related]
33. Measurement properties of instruments assessing psoriatic arthritis symptoms for psoriasis clinical trials: a systematic literature review.
Perez-Chada LM; Balak D; Cohen JM; Ogdie A; Merola JF; Gottlieb AB
Expert Rev Clin Immunol; 2020 Mar; 16(3):267-283. PubMed ID: 32037912
[No Abstract] [Full Text] [Related]
34. 67th annual meeting of the American Academy of Dermatology: San Francisco, California, USA, 6-10 March 2009.
Fraser K
Am J Clin Dermatol; 2009; 10(3):205-10. PubMed ID: 19354337
[No Abstract] [Full Text] [Related]
35. Virtual group visits to reduce psychosocial distress and racial disparities in pediatric vitiligo and alopecia areata patients.
Khosla NN; Grullon K; Rosenblatt AE
Pediatr Dermatol; 2021 Nov; 38 Suppl 2():132-134. PubMed ID: 34448243
[TBL] [Abstract][Full Text] [Related]
36. Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Boehncke WH; Gladman DD
J Rheumatol; 2014 Jun; 41(6):1194-6. PubMed ID: 24882850
[TBL] [Abstract][Full Text] [Related]
37. Zinc in dermatology.
Searle T; Ali FR; Al-Niaimi F
J Dermatolog Treat; 2022 Aug; 33(5):2455-2458. PubMed ID: 35437093
[TBL] [Abstract][Full Text] [Related]
38. PsAPASH: a rare and recent autoinflammatory syndrome associated with hidradenitis suppurativa.
Gadelha RL; Paiva RDSR; Palitot EB; Costa JEFD
An Bras Dermatol; 2020; 95(2):203-206. PubMed ID: 32063421
[TBL] [Abstract][Full Text] [Related]
39. Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting.
Perez-Chada LM; Kohn A; Gottlieb AB; Armstrong AW; Eder L; Mease PJ; Ogdie A; Strand V; Merola JF
J Rheumatol; 2021 Mar; ():. PubMed ID: 33722941
[TBL] [Abstract][Full Text] [Related]
40. Off-label studies on apremilast in dermatology: a review.
Maloney NJ; Zhao J; Tegtmeyer K; Lee EY; Cheng K
J Dermatolog Treat; 2020 Mar; 31(2):131-140. PubMed ID: 30935262
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
